PANP360 Videos

What do PASI, EASI, SALT, and ACR actually do for us in everyday practice? Here, Jill Cowan, NP, breaks down the role of validated scoring tools—not as numbers to memorize but as frameworks that help us communicate treatment expectations, evaluate response, and bring clinical trial results into meaningful patient discussions. This teaser leads into our upcoming full breakdown on applying scoring tools at the point of care. Question: Which of the following best describes the purpose of using validated clinical trial scales such as SALT, PASI, EASI, or ACR in dermatology practice? They are primarily designed to simplify documentation for insurance paperwork. They standardize how disease severity and treatment response are measured, enabling consistent, objective interpretation of clinical and research findings. They eliminate the need for clinical assessment by replacing it with numerical scoring. They are only useful in clinical trials and should not inform patient counseling in practice. Rationale: Jill explains that validated scoring tools provide standardized, reliable, and responsive measures of disease severity and treatment response, enabling reproducible evaluation and helping clinicians translate trial results into clear, meaningful expectations for patients. document.querySelectorAll('.mcq-block').forEach(function(block) { const correct = block.getAttribute('data-correct'); const form = block.querySelector('.mcq-form'); const feedback = block.querySelector('.mcq-feedback'); const resultText = block.querySelector('.mcq-result'); form.addEventListener('change', function(e) { const selected = e.target.value; // Log to console (optional) console.log("Selected answer:", selected); // Show feedback feedback.style.display = 'block'; if (selected === correct) { resultText.textContent = "Correct!"; resultText.style.color = "green"; } else { resultText.textContent = "Incorrect"; resultText.style.color = "red"; } }); }); .mcq-block { padding: 1rem; border: 1px solid #ddd; border-radius: 10px; margin: 1.5rem 0; background: #fafafa; } .mcq-question { margin-bottom: 0.75rem; } .mcq-feedback p { margin: 0.3rem 0; }

Nail disease isn’t cosmetic; it’s a clinical signal. NP Nasslynne Lenz discusses how standardized nail scoring can improve consistency in documentation and communication, and how certain nail findings may serve as early clues of psoriatic arthritis. She also highlights how nail assessment can support when to consider PEST screening or rheumatology collaboration. Watch for a briefing on what to look for during nail checks, and why nail evaluation belongs in every psoriasis visit. Question: When evaluating nail involvement in a patient with psoriasis, which of the following best explains why using a standardized nail scoring tool (such as N-NAIL) can meaningfully influence clinical decision-making? It allows clinicians to automatically determine whether the patient meets diagnostic criteria for psoriatic arthritis. It ensures insurance approval for systemic therapies in patients with mild psoriasis. It replaces the need for clinical examination by providing a numeric score that can be tracked over time. It creates a consistent and validated way to capture the extent of nail disease, which may help identify patients at higher risk for psoriatic arthritis and guide when to escalate evaluation or collaborate with rheumatology. Rationale: Nasslynne notes that standardized nail tools bring consistency and clarity to how nail disease is documented, improving communication across clinicians and helping surface clues that may indicate underlying or emerging psoriatic arthritis, even before joint symptoms are obvious. The scoring does not diagnose PsA on its own, but it does support earlier recognition and informed referral or co-management. document.querySelectorAll('.mcq-block').forEach(function(block) { const correct = block.getAttribute('data-correct'); const form = block.querySelector('.mcq-form'); const feedback = block.querySelector('.mcq-feedback'); const resultText = block.querySelector('.mcq-result'); form.addEventListener('change', function(e) { const selected = e.target.value; // Log to console (optional) console.log("Selected answer:", selected); // Show feedback feedback.style.display = 'block'; if (selected === correct) { resultText.textContent = "Correct!"; resultText.style.color = "green"; } else { resultText.textContent = "Incorrect"; resultText.style.color = "red"; } }); }); .mcq-block { padding: 1rem; border: 1px solid #ddd; border-radius: 10px; margin: 1.5rem 0; background: #fafafa; } .mcq-question { margin-bottom: 0.75rem; } .mcq-feedback p { margin: 0.3rem 0; }

If you’ve ever felt buried in acronyms (PASI, DLQI, ACR… and now PEST?), you’re not alone. In this teaser, Henry Yu, PA-C, reflects on the quiet clues we sometimes overlook and why speaking a shared language across specialties matters. This is the start of a full-circle look at psoriasis, psoriatic arthritis, and the tools that help us catch what’s easy to miss